This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Institute for Cancer Research, University of Hawai'i. Active years: 2019.
Company Filing History:
1 out of 69 
1 out of 267 
Years Active: 2019
Title: Joseph R Testa: Innovator in Cancer Diagnosis
Introduction
Joseph R Testa is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cancer research, particularly in the area of genetic predisposition to cancer. His work has implications for early diagnosis and personalized medicine.
Latest Patents
Joseph R Testa holds a patent for "Methods for diagnosing a predisposition to develop cancer." This patent encompasses systems, methods, and computer-readable media designed to diagnose or characterize a genetic predisposition to develop cancer. The technology involves sequencing or probing nucleic acids that comprise a germline nucleic acid sequence encoding the BRCA1 associated protein 1. This process helps determine if the nucleic acid sequence includes alterations that may predispose a subject to develop cancer. He has 1 patent to his name.
Career Highlights
Throughout his career, Joseph R Testa has worked with esteemed institutions such as the Institute for Cancer Research and the University of Hawai'i. His research has focused on understanding the genetic factors that contribute to cancer, which is crucial for developing effective diagnostic tools and treatments.
Collaborations
Joseph has collaborated with notable colleagues in his field, including Michele Carbone and Jianming Pei. Their combined expertise has furthered research in cancer genetics and diagnostics.
Conclusion
Joseph R Testa's innovative work in cancer diagnosis highlights the importance of genetic research in the fight against cancer. His contributions pave the way for advancements in early detection and personalized treatment options.